Integrated Genomic and Clinicopathologic Approach Distinguishes Pancreatic Grade 3 Neuroendocrine Tumor From Neuroendocrine Carcinoma and Identifies a Subset With Molecular Overlap
Authors:
- 10 January 2023
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 36 (3) , 100065
Abstract
No abstract availableKeywords
Funding Information
- University of California, San Francisco
This publication has 48 references indexed in Scilit:
- Are G3 ENETS neuroendocrine neoplasms heterogeneous?Endocrine-Related Cancer, 2013
- DELLY: structural variant discovery by integrated paired-end and split-read analysisBioinformatics, 2012
- Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine TumorsAmerican Journal of Surgical Pathology, 2012
- A framework for variation discovery and genotyping using next-generation DNA sequencing dataNature Genetics, 2011
- DAXX / ATRX , MEN1 , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine TumorsScience, 2011
- A map of human genome variation from population-scale sequencingNature, 2010
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataGenome Research, 2010
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing dataNucleic Acids Research, 2010
- Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short readsBioinformatics, 2009
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009